Treating classical Hodgkin lymphoma that is refractory to salvage chemotherapy

As part of our biannual steering committee meeting, Astrid Pavlovsky, Fundaleu, Beunos Aires, AR, chaired a case study discussion session on treating a patient with primary refractory classical Hodgkin lymphoma that is refractory to salvage chemotherapy. Steering committee members shared their thoughts and engaged in a lively discussion on how to best treat the 22 year-old patient.